Clinical Trial Update: A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 study of TAK-500 with or without pembrolizumab in adults with select locally advanced or metastatic solid tumors; the trial was terminated and resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Esophageal Cancer
• Gastric Cancer
• Hepatocellular Carcinoma
• Mesothelioma
• Nasopharyngeal Cancer
• Non-small Cell Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• TAK-500

Snippet

Sponsor: Takeda | Conditions: Pancreatic Cancer, Hepatocellular Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2026-01-22